$6.88
-0.04 (-0.58%)
AHMA News2 articles
Lilly's $1.5B Oral Obesity Pill Stockpile Signals Major Launch Ambitions
Eli Lilly has accumulated $1.5 billion in pre-launch inventory for its experimental oral obesity treatment orforglipron, with the FDA's target decision date set for April 10. The substantial stockpile highlights the company's push to overcome supply limitations that have hampered the GLP-1 market.
Meta's AI Ambitions Spark Investor Concern Over Soaring Capital Expenditure
Meta shares declined as the company projected 2026 capital spending could reach $135 billion, nearly double its 2025 forecast, raising investor anxiety about AI investment returns.